Standard Operating Procedure for Regulatory Policy Change Impact Assessment
| Department | Regulatory Affairs |
| SOP No. | RA/2026/626 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 08/04/2026 |
| Effective Date | 08/04/2026 |
| Review Date | 08/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a consistent and systematic approach for Regulatory Affairs and related functions to identify, evaluate, and manage the impact of changes in regulatory policies on the organization’s operations, products, and documentation. It supports the control objective of ensuring compliance with current regulatory requirements, mitigating risks of non-compliance, and maintaining timely updates to internal processes, submissions, and quality systems.
Scope
This SOP applies to all regulatory policy change impact assessments across all functional areas, including but not limited to manufacturing, quality assurance, quality control, laboratory, engineering, validation, calibration, warehousing, and documentation departments. It encompasses assessment of regulatory documents affecting dosage forms, processes, equipment, validations, and quality systems. Excluded are internal procedural changes not driven by external regulatory policy revisions.
Responsibilities
- Regulatory Affairs Team: Responsible for monitoring regulatory sources, identifying changes, and initiating the impact assessment process.
- Department Heads: Participate in impact evaluation relevant to their function and provide technical inputs on affected processes or systems.
- Quality Assurance: Review and approve assessment outcomes, ensuring integration into compliance frameworks.
- Documentation Control: Update necessary documents and ensure controlled distribution post-assessment.
- Compliance Officer: Ensure corrective and preventive actions associated with the policy change are implemented and monitored.
Accountability
The Regulatory Affairs Manager holds overall accountability for effective implementation, adherence, review, escalation of unresolved issues, and periodic evaluation of the SOP’s effectiveness in managing regulatory policy changes impacting the organization.
Procedure
1. Preparation and Monitoring: Regulatory Affairs continuously monitors applicable regulatory bodies, industry publications, and official notifications for policy updates, advisories, and guideline revisions. A regulatory watch log is maintained and reviewed weekly.
2. Notification and Initial Screening: Upon identification of a policy change, Regulatory Affairs logs the notification including source, summary, effective dates, and relevance. Initial screening confirms applicability to the organization’s products, processes, or systems.
3. Formation of Impact Assessment Team: Relevant stakeholders from affected departments are designated for detailed evaluation. This team reviews the new policy’s content, focusing on requirements, timelines, and potential implementation impacts.
4. Detailed Impact Analysis: The team assesses affected areas including technical, procedural, quality systems, documentation, training, and compliance implications. Risk assessments and gap analyses are performed to identify discrepancies between current state and new requirements.
5. Development of Implementation Plan: Based on analysis, an action plan detailing required changes, responsible parties, timelines, resources, and verification methods is prepared. This plan ensures regulatory compliance and operational continuity.
6. Review and Approval: The completed impact assessment report and implementation plan are submitted to Quality Assurance and Regulatory Affairs management for review and formal approval. Comments and corrective recommendations are incorporated before finalization.
7. Execution and Monitoring: Approved plans are executed by designated departments with progress monitored through regular meetings and status reports. Deviations or obstacles are documented, investigated, and escalated as necessary.
8. Documentation and Record Retention: All records related to the policy change, impact assessments, approvals, implementation activities, training, and verification results are documented and maintained per regulatory and company requirements.
9. Closure and Effectiveness Review: After implementation, a formal closure review confirms compliance with the new policy, documents lessons learned, and updates SOPs, training materials, and quality systems accordingly. Periodic reviews assess long-term effectiveness.
10. Communication: Throughout the process, internal communication ensures all relevant personnel are informed of changes, timelines, and compliance expectations.
Abbreviations
- RA: Regulatory Affairs
- QA: Quality Assurance
- SOP: Standard Operating Procedure
- GMP: Good Manufacturing Practice
- CAPA: Corrective and Preventive Action
- CA: Change Assessment
Documents
- Regulatory Policy Change Impact Assessment Report (Annexure-1)
- Regulatory Watch Log (Annexure-2)
- Implementation Plan and Status Report Template (Annexure-3)
References
- ICH Q10 – Pharmaceutical Quality System
- EU GMP Annex 11 – Computerised Systems
- FDA 21 CFR Part 11 – Electronic Records and Signatures
- ISO 9001:2015 – Quality Management Systems Requirements
- Company Quality Management System (QMS) Policies and Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Policy Change Impact Assessment Report
| Field | Details |
|---|---|
| Policy Title | Updated Guidelines for Validation of Manufacturing Equipment |
| Policy Source | Global Regulatory Authority – Notification Ref GA/2026/45 |
| Date of Issue | 15/03/2026 |
| Effective Date | 01/07/2026 |
| Summary of Changes | New requirements for documentation of cleaning validation and periodic re-qualification intervals. |
| Departments Impacted | Manufacturing, QA, Engineering, Validation |
| Impact Assessment | Significant changes to validation protocols, additional documentation requirements, and training needs identified. |
| Recommended Actions | Revise validation SOPs, update training plans, notify vendors, schedule re-qualification activities. |
| Prepared By | Regulatory Affairs Team |
| Date | 22/03/2026 |
| Reviewed By | |
| Approved By |
Annexure-2: Regulatory Watch Log
| Date Logged | Source | Notification Reference | Summary | Impact Status | Action Required |
|---|---|---|---|---|---|
| 15/03/2026 | Global Regulatory Authority | GA/2026/45 | Updated validation documentation requirements | Assessment in progress | Initiate impact assessment |
| 28/02/2026 | International Pharmacopoeia | IP/2026/12 | Revised specifications for raw materials | No impact | Monitor only |
| 05/03/2026 | Health Authority Bulletin | HAB/2026/08 | New record retention requirements | Moderate | Update document control SOP |
Annexure-3: Implementation Plan and Status Report Template
| Task Description | Responsible Department | Target Completion Date | Status | Comments |
|---|---|---|---|---|
| Revise Validation SOPs to incorporate new documentation needs | Validation | 15/05/2026 | In Progress | Draft under review |
| Train affected staff on revised policy and procedures | Quality Assurance | 30/05/2026 | Pending | Training plan to be finalized |
| Schedule re-qualification activities as per new intervals | Engineering | 31/06/2026 | Pending | Awaiting approval of validation revisions |
| Update document control system with revised SOP versions | Documentation Control | 10/06/2026 | Not Started | Dependent on SOP revisions completion |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 08/04/2026 | 1.0 | Initial issue | New SOP creation |